Cargando…

Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib

Detalles Bibliográficos
Autores principales: Winthrop, Kevin L, Wouters, Ann, Choy, Ernest H, Chen, Connie, Biswas, Pinaki, Wang, Lisy, Soma, Koshika, Needle, Elie, Valdez, Hernan, Rigby, William FC
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213307/
https://www.ncbi.nlm.nih.gov/pubmed/32161057
http://dx.doi.org/10.1136/annrheumdis-2019-216566
_version_ 1783531776132513792
author Winthrop, Kevin L
Wouters, Ann
Choy, Ernest H
Chen, Connie
Biswas, Pinaki
Wang, Lisy
Soma, Koshika
Needle, Elie
Valdez, Hernan
Rigby, William FC
author_facet Winthrop, Kevin L
Wouters, Ann
Choy, Ernest H
Chen, Connie
Biswas, Pinaki
Wang, Lisy
Soma, Koshika
Needle, Elie
Valdez, Hernan
Rigby, William FC
author_sort Winthrop, Kevin L
collection PubMed
description
format Online
Article
Text
id pubmed-7213307
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-72133072020-05-14 Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib Winthrop, Kevin L Wouters, Ann Choy, Ernest H Chen, Connie Biswas, Pinaki Wang, Lisy Soma, Koshika Needle, Elie Valdez, Hernan Rigby, William FC Ann Rheum Dis Letter BMJ Publishing Group 2020-05 2020-03-11 /pmc/articles/PMC7213307/ /pubmed/32161057 http://dx.doi.org/10.1136/annrheumdis-2019-216566 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Letter
Winthrop, Kevin L
Wouters, Ann
Choy, Ernest H
Chen, Connie
Biswas, Pinaki
Wang, Lisy
Soma, Koshika
Needle, Elie
Valdez, Hernan
Rigby, William FC
Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib
title Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib
title_full Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib
title_fullStr Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib
title_full_unstemmed Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib
title_short Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib
title_sort long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213307/
https://www.ncbi.nlm.nih.gov/pubmed/32161057
http://dx.doi.org/10.1136/annrheumdis-2019-216566
work_keys_str_mv AT winthropkevinl longtermeffectivenessofliveherpeszostervaccineinpatientswithrheumatoidarthritissubsequentlytreatedwithtofacitinib
AT woutersann longtermeffectivenessofliveherpeszostervaccineinpatientswithrheumatoidarthritissubsequentlytreatedwithtofacitinib
AT choyernesth longtermeffectivenessofliveherpeszostervaccineinpatientswithrheumatoidarthritissubsequentlytreatedwithtofacitinib
AT chenconnie longtermeffectivenessofliveherpeszostervaccineinpatientswithrheumatoidarthritissubsequentlytreatedwithtofacitinib
AT biswaspinaki longtermeffectivenessofliveherpeszostervaccineinpatientswithrheumatoidarthritissubsequentlytreatedwithtofacitinib
AT wanglisy longtermeffectivenessofliveherpeszostervaccineinpatientswithrheumatoidarthritissubsequentlytreatedwithtofacitinib
AT somakoshika longtermeffectivenessofliveherpeszostervaccineinpatientswithrheumatoidarthritissubsequentlytreatedwithtofacitinib
AT needleelie longtermeffectivenessofliveherpeszostervaccineinpatientswithrheumatoidarthritissubsequentlytreatedwithtofacitinib
AT valdezhernan longtermeffectivenessofliveherpeszostervaccineinpatientswithrheumatoidarthritissubsequentlytreatedwithtofacitinib
AT rigbywilliamfc longtermeffectivenessofliveherpeszostervaccineinpatientswithrheumatoidarthritissubsequentlytreatedwithtofacitinib